Magnetic Resonance Imaging in Paediatric Constipation
Launched by NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST · Jun 8, 2018
Trial Information
Current as of April 24, 2025
Completed
Keywords
ClinConnect Summary
One in ten children worldwide has constipation and it becomes chronic in 30% of these children, affecting their and their families' well-being. Managing these children is difficult, partly because they do not respond to laxatives and partly because their bowel problem cannot be defined. If the doctors could send the children for a quick test that indicates the time that food takes to travel through the gut (the "gut transit time"), they could use this information to help choose the best therapy, for example to decide if a patient needs surgery. The test could also be used to follow up the e...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 7 - 18 years old
- • Male or female
- • Able to give assent or have a parent able to give informed consent
- • Willing to allow their GP or consultant, if appropriate, to be notified of participation in the clinical investigation
- • Presenting with intractable constipation at secondary or tertiary care and considered for possible treatment which may include new drugs or procedures (Group1 only)
- • Healthy bowel habit and does not suffer from constipation or diarrhoea (Group 2 only)
- Exclusion Criteria:
- • Female participants who are pregnant, lactating or planning pregnancy during the course of the investigation.
- • Any history of gastrointestinal surgery such as colectomy or small bowel resection.
- • Existing ACE procedure before the first MRI scan (Group 1 only)
- • Significant renal or hepatic impairment
- • Contraindications for MRI scanning such as metallic implants and penetrating eye injury.
- • Inability to lie flat and relatively still for less than 5 minutes
- • Poor understanding of English language
- • Any other significant disease or disorder (other than intractable constipation for Group 1)
- • Participation in another research clinical investigation involving an investigational product in the past 12 weeks.
Trial Officials
Pauline H Taylor
Study Director
Nottingham University Hospitals NHS Trust
About Nottingham University Hospitals Nhs Trust
Nottingham University Hospitals NHS Trust is a leading healthcare provider in the UK, dedicated to delivering high-quality patient care and advancing medical research. Comprising two major hospitals, Queen's Medical Centre and Nottingham City Hospital, the Trust is at the forefront of clinical innovation and education. With a strong emphasis on translational research, Nottingham University Hospitals NHS Trust actively sponsors clinical trials aimed at improving treatment outcomes and understanding various health conditions. The Trust collaborates with academic institutions, healthcare professionals, and industry partners to foster a robust research environment that enhances clinical practice and contributes to evidence-based medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nottingham, Nottinghamshire, United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials